Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: the Lupus Nephritis Assessment with Rituximab study.
about
Lupus Nephritis: A Different Disease in European Patients?Lupus Nephritis in Asia: Clinical Features and ManagementCurrent and emerging treatment options in the management of lupusTargeted therapeutics in SLE: emerging strategies to modulate the interferon pathwayManagement of Neuropsychiatric Systemic Lupus Erythematosus: Current Approaches and Future PerspectivesKey issues in the management of patients with systemic lupus erythematosus: latest developments and clinical implicationsBelimumab in systemic lupus erythematosusUse of biologics in SLE: a review of the evidence from a clinical perspectiveNon-invasive imaging to monitor lupus nephritis and neuropsychiatric systemic lupus erythematosusMeasuring disease activity in adults with systemic lupus erythematosus: the challenges of administrative burden and responsiveness to patient concerns in clinical researchCellular targeting in autoimmunityPolychromatic flow cytometry in evaluating rheumatic disease patientsProfile of atacicept and its potential in the treatment of systemic lupus erythematosusType I interferon blockade in systemic lupus erythematosus: where do we stand?Understanding the role of B cells in atherosclerosis: potential clinical implicationsEffect of TACI signaling on humoral immunity and autoimmune diseasesB cells take the front seat: dysregulated B cell signals orchestrate loss of tolerance and autoantibody productionLupus nephritis: the evolving role of novel therapeuticsUnmet medical needs in systemic lupus erythematosusRituximab and its therapeutic potential in catastrophic antiphospolipid syndromeApproaches for estimating minimal clinically important differences in systemic lupus erythematosusRituximab in autoimmune diseasesPathogenesis of renal disease in systemic lupus erythematosus--the role of autoantibodies and lymphocytes subset abnormalitiesMechanisms of autoantibody production in systemic lupus erythematosusPathogenic Inflammation and Its Therapeutic Targeting in Systemic Lupus ErythematosusWhat is new in the management of rapidly progressive glomerulonephritis?Crossing the Atlantic: the Euro-Lupus Nephritis regimen in North AmericaThe pathogenesis of systemic lupus erythematosus—an updateTreatment of primary Sjögren syndrome.B cells and atherosclerosis.CD20-Mimotope Peptide Active Immunotherapy in Systemic Lupus Erythematosus and a Reappraisal of Vaccination Strategies in Rheumatic Diseases.Patient-reported outcomes in lupus clinical trials with biologics.The pathogenesis, diagnosis and treatment of lupus nephritis.Prospective data collection of off-label use of rituximab in Australian public hospitals.Efficacy and safety of atacicept for prevention of flares in patients with moderate-to-severe systemic lupus erythematosus (SLE): 52-week data (APRIL-SLE randomised trial).Lupus pathobiology based on genomics.Anti B-cell therapy against refractory thrombocytopenia in SLE and MCTD patients: long-term follow-up and review of the literature.Early-onset neutropenia induced by rituximab in a patient with lupus nephritis and hemolytic anemiaEfficacy of abatacept in systemic lupus erythematosus: a retrospective analysis of 11 patients with refractory disease.The effect of rituximab therapy on immunoglobulin levels in patients with multisystem autoimmune disease.
P2860
Q26740483-A465A9B2-6EAD-4A1C-9ED3-1F5E9B43990AQ26740487-A813D633-AFF5-49E8-8F47-3815D33A689FQ26741266-39672775-7121-4D44-B98C-64E5840ADA1AQ26746697-FD18FA81-52E3-4813-A7DA-081FDC923BEBQ26774815-0D8A2EF1-BAD0-4AE3-AA38-F5EA26BFBB9FQ26775756-E197C5C9-8377-46C0-9300-B24619B1EA22Q26778277-668A21C5-5ACE-426E-B979-2F12D6910A2AQ26783652-8D441087-21D9-4749-B825-DD47E9C2EB75Q26796871-0CE096B2-1A6B-4438-904E-AE03DEDCA7DFQ26799223-3619C255-B45B-487A-975B-8237CDEE4412Q26824580-08CACE45-4A7B-4943-9CCB-860DC72CDEBEQ26827075-58D502DF-A4A0-4BBC-B20B-9AFCAE01684EQ26849719-C5C0827B-6044-44A5-9613-001D41B09818Q26865441-51344F88-A205-4BD6-B7C6-F2DC6103C470Q26991813-FC77C2A2-00FA-401B-B195-FCE3A2FFAA67Q26995571-01D21EA2-CB88-47FB-9116-FFD99D5A8868Q26996644-B9DDE70E-F28B-4BC8-9B37-D02C29D523E7Q26998390-022727EA-E654-40C0-8BC2-5886122656F6Q27005906-09101439-BEB3-43A6-A3AE-491C078A8D69Q27021256-2E8DD433-02E8-4B4F-9DAD-8D2731B96B3FQ27021623-B63341F0-9FC0-4FA1-BDEE-613CCE38BE64Q28076091-A7D60D52-CBEB-4343-9255-FC22163B31E8Q28080571-AAC86818-786B-4566-9BAC-F7A2CB13E775Q28082507-E48E8CE4-2EDB-449F-B9AB-1E7F8CC337B5Q28088753-F63BB9E6-69A3-4E02-B121-6F2C84B294AFQ28259540-3C6206FE-3D9F-461C-BF2A-90BF136AA226Q28645743-3FBAD8C4-6EB9-43B1-906D-54EC94AA54AEQ29394347-74A895CD-9EB5-418B-B8D5-D8233DEA214DQ30249011-B922A590-56A3-4473-A14E-A0D7388AC0BEQ30252928-FB75C98F-CC15-443D-A2DF-4E3DD66BC0EEQ30388433-4927B8BF-0255-444C-9E84-87FF4CB699D7Q30391564-0EDD34D5-11AF-46B1-B116-727C5110DEF2Q30596968-31173204-EB02-492B-865F-E0FF4F849E3CQ30640279-A01442A1-F344-4E28-AE41-0D0CACFA628CQ30832522-161CBDB3-C83E-4122-8BC9-84B9A4875D63Q33364409-3BE83194-73A1-403F-8A33-FF389B3DA572Q33407247-CE7501F3-988F-404B-B37B-7625AAA03470Q33421190-1F111E2F-8198-44D5-91F1-402F645CDE65Q33431030-8D79C783-9C49-4B37-8FF4-8B8CF93D3639Q33683956-CE63F826-F5EE-474E-89D5-10AE31C11BDB
P2860
Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: the Lupus Nephritis Assessment with Rituximab study.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Efficacy and safety of rituxim ...... sessment with Rituximab study.
@en
type
label
Efficacy and safety of rituxim ...... sessment with Rituximab study.
@en
prefLabel
Efficacy and safety of rituxim ...... sessment with Rituximab study.
@en
P2093
P2860
P356
P1476
Efficacy and safety of rituxim ...... sessment with Rituximab study.
@en
P2093
Brad H Rovin
David Zhang
Fernando C Fervenza
Gerald Appel
Jay P Garg
Jorge Sanchez-Guerrero
Kevin Latinis
LUNAR Investigator Group
Paul Brunetta
R John Looney
P2860
P304
P356
10.1002/ART.34359
P577
2012-01-09T00:00:00Z